Intraperitoneal injection of SMAD7 antisense oligonucleotides, in contrast, attenuates tumor burden in mice transplanted with human colorectal cells-derived xenografts, likely a reflection of, in part, a reduction in tumor cell growth [68]. Here, SMAD7 is linked to neoplasm.